RGNX MEXC RealStocks
Own real RGNX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 22:43:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
REGENXBIO Inc. (RGNX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $8.03, with a market capitalization of $508.48M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.46 to $16.19. This page covers its latest market performance, valuation, price trends and company information.
$508.48M | |
$8.23 | |
$8.57 | |
$7.94 | |
$8.47 | |
1.11M | |
1.40M | |
-- | |
$16.19 | |
$5.46 | |
-- | |
-- |
REGENXBIO Inc. (RGNX) is trading at $8.19 in after-hours trading as of 2026-11-12 22:21:00, up 2.08% ($0.17) from the regular-session close of $8.03.
After-hours trading shows how investors are pricing RGNX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, REGENXBIO Inc. (RGNX) moved from $7.63 to $8.03, representing a gain of 5.19% ($0.40).
The stock traded between $7.15 and $8.88 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 1.45 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 23.9%
RGNX is currently trading at $8.03, placing it 23.9% of the way from its 52-week low of $5.46 to its 52-week high of $16.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 371 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for REGENXBIO Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of REGENXBIO Inc. (RGNX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to RGNX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between RGNX shares and USD.
RGNX Shares to USD
1.00 RGNX shares = 8.026 USD
Calculations are estimates based on the latest available price and are for reference only.